Chronic LPS exposure produces changes in intrinsic membrane properties and a sustained IL-β-dependent increase in GABAergic inhibition in hippocampal CA1 pyramidal neurons
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Chronic inflammation has been reported to be a significant factor in the induction and progression of a number of chronic neurological disorders including Alzheimer's disease and Down syndrome. It is believed that inflammation may promote synaptic dysfunction, an effect that is mediated in part by pro-inflammatory cytokines such as interleukin-1beta (IL-1beta). However, the role of IL-1beta and other cytokines in synaptic transmission is still poorly understood. In this study, we have investigated how synaptic transmission and neuronal excitability in hippocampal pyramidal neurons are affected by chronic inflammation induced by exposing organotypic slices to the bacterial cell-wall product lipopolysaccharide (LPS). We report that CA1 pyramidal neurons recorded in whole cell from slices previously exposed to LPS for 7 days had resting membrane potential and action potential properties similar to those of the controls. However, they had significantly lower membrane resistance and a more elevated action potential threshold, and displayed a slower frequency of action potential discharge. Moreover, the amplitude of pharmacologically isolated postsynaptic gamma-aminobutyric acid (GABA)ergic potentials, but not excitatory glutamatergic postsynaptic potentials, was significantly larger following chronic LPS exposure. Interestingly, co-incubation of the IL-1 receptor antagonist (IL-1Ra) concurrently with LPS prevented the increase in GABAergic transmission, but not the reduction in intrinsic neuronal excitability. Finally, we confirmed that LPS dramatically increased IL-1beta, and IL-1beta-dependent IL-6 levels in the culture medium for 2 days before returning to baseline. We conclude that CA1 pyramidal neurons in slices chronically exposed to LPS show a persistent decrease in excitability due to a combined decrease in intrinsic membrane excitability and an enhancement in synaptic GABAergic input, the latter being dependent on IL-1beta. Therefore, chronic inflammation in hippocampus produces IL-1beta-dependent and -independent effects in neuronal and synaptic function that could contribute significantly to cognitive disturbances.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Liu, B., & Hong, J.-S. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.035048 · Cited by 1,095
Lehnardt, S., Massillon, L., Follett, P., Jensen, F. E., Ratan, R., Rosenberg, P. A., Volpe, J. J., & Vartanian, T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432609100 · Cited by 1,052
Viviani, B., Bartesaghi, S., Gardoni, F., Vezzani, A., Behrens, M. M., Bartfai, T., Binaglia, M., Corsini, E., Di Luca, M., Galli, C. L., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-25-08692.2003 · Cited by 893
Kleschevnikov, A. M., Belichenko, P. V., Villar, A. J., Epstein, C. J., Malenka, R. C., & Mobley, W. C. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1766-04.2004 · Cited by 459 · cited 2×
“…an enhancement in GABAergic inhibition similar to what we observed could underlie these effects, as it is well established that increases in GABAergic inhibition can reduce PPF and hinder LTP induction (Davies et al., 1990; Kuenzi et al., 2000; Meredith et al., 2003; Kleschevnikov et al., 2004).”
BackgroundResultCunningham, A. J., Murray, C. A., O'Neill, L. A. J., Lynch, M. A., & O'Connor, J. J. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(95)12252-4 · Cited by 433 · cited 11×
“This is reminiscent of previous reports demonstrating that endogenous IL-1b in normal physiological conditions may also be necessary for the establishment of LTP (Schneider et al., 1998; Coogan et al., 1999; Ross et al., 2003) and is required for hippocampal-dependent memory formation (Avital et al., 2003).”
BackgroundInfluentialThe impact of systemic infection on the progression of neurodegenerative disease
Perry, V. H., Newman, T. A., & Cunningham, C. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1032 · Cited by 428 · cited 1×
“…event in the induction and progression of chronic neurodegenerative disorders such as human immunodeficiency virus-acquired immunodeficiency syndrome (HIV-AIDS) dementia, Alzheimer’s disease, and Down/trisomy 21 syndrome (Ringheim and Conant, 2004; Perry et al., 2003; Hunter et al., 2004).”
BackgroundThe LPS receptor (CD14) links innate immunity with Alzheimer's disease
Fassbender, K., Walter, S., Kühl, S., Landmann, R., Ishii, K., Bertsch, T., Stalder, A. K., Muehlhauser, F., Liu, Y., Ulmer, A. J., et al. (2004) · The FASEB Journal · doi:10.1096/fj.03-0364fje · Cited by 307 · cited 1×
“LPS has been used extensively in investigating mechanisms of brain inflammation, especially in relation to the development and progression of neural disorders such as AD (Fassbender et al., 2004).”
Coogan, A. N., O'Neill, L. A. J., & O'Connor, J. J. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00100-1 · Cited by 129 · cited 10×
“This is reminiscent of previous reports demonstrating that endogenous IL-1b in normal physiological conditions may also be necessary for the establishment of LTP (Schneider et al., 1998; Coogan et al., 1999; Ross et al., 2003) and is required for hippocampal-dependent memory formation (Avital et al., 2003).”
BackgroundResultInfluential
Cited by
Sepsis-associated encephalopathy
Gofton, T. E., & Young, G. B. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.183 · Cited by 821
Cytokines and brain excitability
Galic, M. A., Riazi, K., & Pittman, Q. J. (2012) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2011.12.002 · Cited by 446
Frenois, F., Moreau, M., O’Connor, J., Lawson, M., Micon, C., Lestage, J., Kelley, K. W., Dantzer, R., & Castanon, N. (2007) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2007.03.005 · Cited by 438
“This LPS-induced IL1-β expression is responsible for a sustained increase in GABAergic inhibition in hippocampal CA1 pyramidal neurons (Hellstrom et al., 2005).”
BackgroundThe influence of neuroinflammation in Autism Spectrum Disorder
Matta, S. M., Hill-Yardin, E. L., & Crack, P. J. (2019) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2019.04.037 · Cited by 416
Chen, J., Buchanan, J. B., Sparkman, N. L., Godbout, J. P., Freund, G. G., & Johnson, R. W. (2008) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2007.08.014 · Cited by 398
Neuroinflammation and microglia: considerations and approaches for neurotoxicity assessment
Harry, G. J., & Kraft, A. D. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.10.1265 · Cited by 295
Ebersoldt, M., Sharshar, T., & Annane, D. (2007) · Intensive Care Medicine · doi:10.1007/s00134-007-0622-2 · Cited by 291
Sepsis-associated encephalopathy and its differential diagnosis
Iacobone, E., Bailly-Salin, J., Polito, A., Friedman, D., Stevens, R. D., & Sharshar, T. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181b6ed58 · Cited by 266
A critical review of human endotoxin administration as an experimental paradigm of depression.
DellaGioia, N., & Hannestad, J. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.07.014 · Cited by 175
Crowley, T., Cryan, J. F., Downer, E. J., & O’Leary, O. F. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2016.02.001 · Cited by 150
Reelin-mediated signaling in neuropsychiatric and neurodegenerative diseases
Knuesel, I. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.04.002 · Cited by 89
Varodayan, F. P., Pahng, A. R., Davis, T. D., Gandhi, P., Bajo, M., Steinman, M. Q., Kiosses, W. B., Blednov, Y. A., Burkart, M. D., Edwards, S., et al. (2023) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2023.02.020 · Cited by 50
Rodent Modeling of Alzheimer's Disease in Down Syndrome: In vivo and ex vivo Approaches
Farrell, C., Mumford, P., & Wiseman, F. K. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.909669 · Cited by 22
Effects of MFHAS1 on cognitive impairment and dendritic pathology in the hippocampus of septic rats
Zhong, J., Guo, C., Hou, W., Shen, N., & Miao, C. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116822 · Cited by 15
Daulatzai, M. A. (2015) · Neurotoxicity Research · doi:10.1007/s12640-015-9528-x · Cited by 12
“This is because the inflammatory cytokines impair synaptic plasticity in the DG and CA regions of the hippocampus (Bellinger et al. 1993; Hellstrom et al. 2005; Rosi et al. 2005a, b; Shaw et al. 2005; Pickering and O’Connor 2007).”
Background
Metadata
- Authors
- Hellstrom, I. C., Danik, M., Luheshi, G. N., & Williams, S.
- Venue
- Hippocampus
- Publisher
- Wiley
- Published
- 2005
- Volume
- 15
- Issue
- 5
- Pages
- 656-664
- ISSN
- 1050-9631 (ISSN-L)
- 1098-1063
- OpenAlex
- W2046062795
- Cited by
- 117
- References
- 8
- FWCI
- 3.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.